Jupiter Life Science Consulting Launches New Subscription-Based Market Research Solution for Pharma and Biotech Industries

Jupiter Life Science Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, today announced the launch of its payer engagement solution, Quick Qual (Q²). Jupiter’s new payer intelligence service ensures pharma and biotech innovators are equipped with immediate payer insights to meet growing market access demands and optimize commercial strategies.

Through Jupiter’s Q² expert panelists, representing the nation’s leading national health insurance and pharmacy benefit manager organizations, Q² delivers valuable payer intelligence, quickly addressing key issues and providing time-sensitive insights enabling accelerated go-to-market strategies. The Q² panel also allows Jupiter to break from industry standard survey systems, which are often slow-moving and gather data on general topics rather than specific examples.

“Biopharma’s market access environment continues to rapidly evolve, which means our clients need new solutions to remain competitive in today’s market,” said Steve Slovick, CEO and managing partner, Jupiter Life Science Consulting. “Biopharma stakeholders must understand how these changes impact brand access and strategy. Our Q² solution empowers the biopharma industry to avoid costly delays, as well as identify and develop comprehensive strategies that address hot-button issues in record time.”

Q² Key Capabilities Include:


  • Access to a dedicated panel of payer key decision makers: Q² gathers insights from a consistent, dedicated panel of key payer decision makers from leading medical and pharmaceutical organizations representing the U.S. health care landscape.
  • Expertise in multiple focus areas: Q² can help with business development, field intelligence, brand insights,…

Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *